ORCID Profile
0000-0002-5573-3055
Current Organisations
Radboud University Nijmegen
,
University of New South Wales
,
PSYTREC
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Publisher: Elsevier BV
Date: 07-2004
Publisher: Elsevier BV
Date: 06-1996
Publisher: Elsevier BV
Date: 08-1993
Publisher: Elsevier BV
Date: 06-2020
Publisher: Wiley
Date: 07-04-2011
Publisher: Springer Science and Business Media LLC
Date: 09-2003
Publisher: Springer Science and Business Media LLC
Date: 06-1995
DOI: 10.1007/BF01212490
Publisher: American Medical Association (AMA)
Date: 05-2017
DOI: 10.1001/JAMAPSYCHIATRY.2016.3955
Abstract: Whether and under which conditions D-cycloserine (DCS) augments the effects of exposure-based cognitive behavior therapy for anxiety, obsessive-compulsive, and posttraumatic stress disorders is unclear. To clarify whether DCS is superior to placebo in augmenting the effects of cognitive behavior therapy for anxiety, obsessive-compulsive, and posttraumatic stress disorders and to evaluate whether antidepressants interact with DCS and the effect of potential moderating variables. PubMed, EMBASE, and PsycINFO were searched from inception to February 10, 2016. Reference lists of previous reviews and meta-analyses and reports of randomized clinical trials were also checked. Studies were eligible for inclusion if they were (1) double-blind randomized clinical trials of DCS as an augmentation strategy for exposure-based cognitive behavior therapy and (2) conducted in humans diagnosed as having specific phobia, social anxiety disorder, panic disorder with or without agoraphobia, obsessive-compulsive disorder, or posttraumatic stress disorder. Raw data were obtained from the authors and quality controlled. Data were ranked to ensure a consistent metric across studies (score range, 0-100). We used a 3-level multilevel model nesting repeated measures of outcomes within participants, who were nested within studies. In idual participant data were obtained for 21 of 22 eligible trials, representing 1047 of 1073 eligible participants. When controlling for antidepressant use, participants receiving DCS showed greater improvement from pretreatment to posttreatment (mean difference, -3.62 95% CI, -0.81 to -6.43 P = .01 d = -0.25) but not from pretreatment to midtreatment (mean difference, -1.66 95% CI, -4.92 to 1.60 P = .32 d = -0.14) or from pretreatment to follow-up (mean difference, -2.98, 95% CI, -5.99 to 0.03 P = .05 d = -0.19). Additional analyses showed that participants assigned to DCS were associated with lower symptom severity than those assigned to placebo at posttreatment and at follow-up. Antidepressants did not moderate the effects of DCS. None of the prespecified patient-level or study-level moderators was associated with outcomes. D-cycloserine is associated with a small augmentation effect on exposure-based therapy. This effect is not moderated by the concurrent use of antidepressants. Further research is needed to identify patient and/or therapy characteristics associated with DCS response.
Publisher: Elsevier BV
Date: 12-2020
Publisher: Oxford University Press
Date: 21-11-2012
DOI: 10.1093/OXFORDHB/9780199734580.013.0018
Abstract: This article attempts to identify treatments of corruption that draw on characteristics of underdevelopment either as causes or as consequences. There is a very small amount of literature (both empirical and theoretical) on corruption in the Indian context. A primary reason for the lack of empirical work is the unavailability of data: Both parties typically benefit from corruption, and, therefore, neither has an incentive to report it. The article looks at three aspects of government corruption in developing countries, and in India in particular: red tape, rent-seeking, and the abundance of intermediaries (such as middlemen). The article argues that if wasteful red tape is specifically a characteristic of public provision (not private), then provision should be privatized, as suggested by the “efficient corruption” literature. The article emphasizes that there is very little work on intermediation (and the role of intermediaries) in corruption, an analysis of which is necessary to understand the structure of corruption markets, especially in the Indian context.
Publisher: Elsevier BV
Date: 08-2022
Publisher: Emerald
Date: 17-04-2009
DOI: 10.1108/17538250910953453
Abstract: Consider a government benefit that is earmarked for a group of people “deserving” the benefit. Corruption happens when undeserving candidates obtain the benefit with the help of corrupt officials. Often, such corrupt activities are mediated by professional touts who act as intermediaries between the undeserving candidates and the corrupt officials. The purpose of this paper is to analyze the equilibrium in such an intermediated market. A queuing model was theoretically analyzed where candidates wait in line to obtain the benefit. Undeserving candidates can also obtain the service – in exchange for a bribe – if they happen to wait at a counter with a corrupt clerk. The intermediary collects information to find out which clerks are corrupt, and charges a fee to direct candidates to an honest or corrupt clerk, as the candidate may choose. In a market with a single intermediary we show that, under fairly general conditions: the intermediary is active both deserving and undeserving candidates use the service of the intermediary welfare in an economy with an intermediary is lower than that in an economy without intermediaries and under some conditions, an optimal response to corruption is to reduce the number of officials dispensing the benefit. This paper provides a framework within which intermediated markets for corruption can be analysed. The framework is easy to adapt and can accommodate social costs other than waiting costs. The conclusion suggests more complex scenarios that may be analysed using the approach in this model.
Publisher: University of Chicago Press
Date: 07-2017
DOI: 10.1086/690713
Publisher: Wiley
Date: 04-2017
DOI: 10.1111/JPET.12174
Publisher: Elsevier BV
Date: 05-2018
Publisher: Elsevier BV
Date: 12-2019
Publisher: Elsevier BV
Date: 05-1996
Publisher: Elsevier BV
Date: 2020
DOI: 10.2139/SSRN.3520613
Publisher: Elsevier BV
Date: 2022
DOI: 10.2139/SSRN.4153734
Publisher: Elsevier BV
Date: 2021
DOI: 10.2139/SSRN.3818198
No related grants have been discovered for Gautam Bose.